oxazoles and Bacterial Skin Diseases
oxazoles has been researched along with Bacterial Skin Diseases in 36 studies
Research
Studies (36)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 32 (88.89) | 24.3611 |
2020's | 4 (11.11) | 2.80 |
Authors
Authors | Studies |
---|---|
Calabuig Muñoz, E; Castells Lao, G; Isernia, V; López Suñé, E; Mensa Pueyo, J; Mensa Vendrell, M; Morata Ruiz, L; Moreno Nuñez, L; Oltra Sempere, MR; Pasquau Liaño, J; Pedro-Botet Montoya, ML; Reynaga Sosa, EA; Salavert Lletí, M; Sequera Arquelladas, S; Soriano Viladomiu, A; Tasias Pitarch, M; Yuste Ara, JR | 1 |
Atlihan-Gundogdu, E; Demir, ES; Karpuz, M; Senyigit, Z | 1 |
Broyde, N; Butterton, JR; Croce, M; De Anda, C; Fujimi, S; Kim, JY; Popejoy, MW; Rodriguez Gonzalez, D; Roquilly, A; Wunderink, RG | 1 |
Kase, M; Kitaoka, A; Kobayashi, S; Matsubara, M; Yasu, T | 1 |
Anuskiewicz, S; De Anda, C; Prokocimer, P; Vazquez, J | 1 |
Anuskiewicz, S; Bidell, M; De Anda, C; Flanagan, S; Hardalo, C; Lodise, TP; Prokocimer, P | 1 |
Iwamoto, Y; Kato, M; Kohno, S; Mikamo, H; Takesue, Y; Tanigawa, T; Tanimura, Y | 1 |
Alder, J; Li, L; Lv, X; O'Riordan, W; Rybak, MJ; Wilcox, MH; Ye, H; Zhang, R; Zhang, Z; Zhu, X | 1 |
Das, A; De Anda, C; Fang, E; Mehra, P; Prokocimer, P | 1 |
Boucher, HW; Doron, S | 1 |
Espona, M; Ferrández, I; Ferrández, O; Grau, S; Salas, E; Urbina, O | 1 |
Spellberg, B | 1 |
Das, A; Prokocimer, P | 1 |
Bien, P; De Anda, C; Prokocimer, P | 1 |
Corey, GR; Das, AF; De Anda, C; Fang, E; Moran, GJ; Prokocimer, P | 1 |
Kern, WV; Tacconelli, E | 1 |
Fiedler-Kelly, J; Flanagan, S; Lu, Q; Ludwig, E; Passarell, J; Prokocimer, P | 1 |
Gras, J | 1 |
Adam, H; Gilmour, M; Gin, AS; Golden, A; Gorityala, B; Hoban, DJ; Karlowsky, JA; Lagacé-Wiens, PR; Love, R; Lynch, JP; Rubinstein, E; Schweizer, F; Walkty, A; Zelenitsky, S; Zhanel, GG | 1 |
Drekonja, DM | 1 |
Taylor, J | 1 |
Corey, GR; Das, AF; Moran, GJ; Prokocimer, P | 1 |
Burdette, SD; Trotman, R | 1 |
Chahine, EB; Knutsen, SD; Sucher, AJ | 1 |
Hui, Y; Xiaoju, L | 1 |
Bassetti, M; Concia, E; Cristini, F; De Rosa, FG; Esposito, S; Menichetti, F; Petrosillo, N; Russo, A; Tumbarello, M; Venditti, M; Viale, P; Viscoli, C | 1 |
Li, R; Nailor, MD | 1 |
Das, AF; De Anda, C; Powers, JH; Prokocimer, P | 1 |
Cao, B; Chen, H; Chu, Y; Du, Y; Feng, X; Fu, Q; Gui, Q; Guo, Y; Hu, B; Hu, Y; Hu, Z; Ji, P; Jia, W; Jin, Y; Lei, JE; Li, S; Liao, K; Liu, Z; Ni, Y; Wang, H; Wang, Z; Xu, X; Yang, Q; Yu, Y; Zeng, J; Zhang, R; Zhang, Z; Zhao, C; Zhuo, C | 1 |
Corey, R; Das, AF; De Anda, C; Nathwani, D; Prokocimer, P; Sandison, T | 1 |
Arber, M; Barata, T; Eales, J; Fleetwood, K; Glanville, J; Gould, IM; Kauf, TL; McCool, R | 1 |
Durkin, MJ; Hsueh, K; Krekel, T; McBride, D | 1 |
Bridgeman, MB; Dalal, KS | 1 |
Das, AF; De Anda, C; Fang, E; Prokocimer, P; Sandison, T | 1 |
Bien, P; Bulitta, JB; Corey, GR; DeAnda, C; Mehra, P; Prokocimer, P; Surber, J | 1 |
Reviews
11 review(s) available for oxazoles and Bacterial Skin Diseases
Article | Year |
---|---|
Clinical safety and tolerability of tedizolid phosphate in the treatment of acute bacterial skin and skin structure infections.
Topics: Acute Disease; Administration, Intravenous; Administration, Oral; Anti-Bacterial Agents; Clinical Trials as Topic; Humans; Linezolid; Organophosphates; Oxazoles; Severity of Illness Index; Skin Diseases, Bacterial | 2018 |
Potential role of tedizolid phosphate in the treatment of acute bacterial skin infections.
Topics: Acute Disease; Animals; Anti-Bacterial Agents; Biological Availability; Drug Resistance, Bacterial; Gram-Positive Bacteria; Humans; Organophosphates; Oxazoles; Skin Diseases, Bacterial; Soft Tissue Infections; Tissue Distribution | 2013 |
Two new drugs for skin and skin structure infections.
Topics: Animals; Anti-Bacterial Agents; Clinical Trials as Topic; Humans; Methicillin-Resistant Staphylococcus aureus; Organophosphates; Oxazoles; Skin Diseases, Bacterial; Staphylococcal Infections; Teicoplanin | 2014 |
Tedizolid phosphate for the treatment of acute bacterial skin and skin structure infections.
Topics: Acute Disease; Animals; Anti-Bacterial Agents; Clinical Trials as Topic; Drug Resistance, Bacterial; Humans; Organophosphates; Oxazoles; Skin Diseases, Bacterial | 2014 |
Tedizolid: a novel oxazolidinone with potent activity against multidrug-resistant gram-positive pathogens.
Topics: Animals; Anti-Bacterial Agents; Clinical Trials as Topic; Drug Resistance, Multiple, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Molecular Structure; Organophosphates; Oxazoles; Skin Diseases, Bacterial | 2015 |
Tedizolid: The First Once-Daily Oxazolidinone Class Antibiotic.
Topics: Anti-Bacterial Agents; Clinical Trials, Phase III as Topic; Drug Interactions; Drug Resistance, Bacterial; Gram-Positive Bacterial Infections; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Organophosphates; Oxazoles; Skin Diseases, Bacterial; Staphylococcal Skin Infections | 2015 |
Tedizolid: A New Oxazolidinone Antibiotic for Skin and Soft Tissue Infections.
Topics: Adult; Anti-Bacterial Agents; Drug Interactions; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Organophosphates; Oxazoles; Skin Diseases, Bacterial; Soft Tissue Infections | 2015 |
Tedizolid for treatment of acute bacterial skin and skin structure infections.
Topics: Acute Disease; Animals; Anti-Bacterial Agents; Clinical Trials as Topic; Drug Resistance, Multiple, Bacterial; Humans; Organophosphates; Oxazoles; Skin Diseases, Bacterial; Treatment Outcome | 2015 |
Current and future trends in antibiotic therapy of acute bacterial skin and skin-structure infections.
Topics: Ambulatory Care; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Glycopeptides; Humans; Lipoglycopeptides; Organophosphates; Oxazoles; Skin Diseases, Bacterial; Staphylococcal Skin Infections; Teicoplanin; United States; United States Food and Drug Administration | 2016 |
Systematic review and network meta-analysis of tedizolid for the treatment of acute bacterial skin and skin structure infections caused by MRSA.
Topics: Anti-Bacterial Agents; Bayes Theorem; Ceftaroline; Cephalosporins; Daptomycin; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Organophosphates; Oxazoles; Oxazolidinones; Skin Diseases, Bacterial; Staphylococcal Infections; Tetrazoles; Vancomycin | 2017 |
Pharmacokinetic drug evaluation of tedizolid for the treatment of skin infections.
Topics: Animals; Anti-Bacterial Agents; Biological Availability; Drug Interactions; Half-Life; Humans; Organophosphates; Oxazoles; Skin Diseases, Bacterial; Soft Tissue Infections | 2017 |
Trials
10 trial(s) available for oxazoles and Bacterial Skin Diseases
Article | Year |
---|---|
A Phase 3, Randomized, Double-Blind Study Comparing Tedizolid Phosphate and Linezolid for Treatment of Ventilated Gram-Positive Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia.
Topics: Anti-Bacterial Agents; Double-Blind Method; Hospitals; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Organophosphates; Oxazoles; Pneumonia, Bacterial; Skin Diseases, Bacterial; Ventilators, Mechanical | 2021 |
Outpatient treatment of acute bacterial skin and skin structure infections (ABSSSI) with tedizolid phosphate and linezolid in patients in the United States: Subgroup analysis of 2 randomized phase 3 trials.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; Anti-Bacterial Agents; Female; Humans; Linezolid; Male; Middle Aged; Organophosphates; Oxazoles; Skin Diseases, Bacterial; Treatment Outcome; United States; Young Adult | 2017 |
Efficacy, safety and pharmacokinetics of tedizolid versus linezolid in patients with skin and soft tissue infections in Japan - Results of a randomised, multicentre phase 3 study.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Female; Humans; Japan; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Organophosphates; Oxazoles; Prospective Studies; Skin Diseases, Bacterial; Soft Tissue Infections; Treatment Outcome | 2018 |
Efficacy and Safety of Tedizolid Phosphate versus Linezolid in a Randomized Phase 3 Trial in Patients with Acute Bacterial Skin and Skin Structure Infection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria; Double-Blind Method; Female; Humans; Male; Middle Aged; Organophosphates; Oxazoles; Skin; Skin Diseases, Bacterial; Young Adult | 2019 |
Tedizolid phosphate vs linezolid for treatment of acute bacterial skin and skin structure infections: the ESTABLISH-1 randomized trial.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Double-Blind Method; Female; Humans; Intention to Treat Analysis; Male; Middle Aged; Organophosphates; Oxazoles; Skin Diseases, Bacterial; Treatment Outcome; Young Adult | 2013 |
Comparison of digital planimetry and ruler technique to measure ABSSSI lesion sizes in the ESTABLISH-1 study.
Topics: Acetamides; Anti-Bacterial Agents; Erythema; Humans; Image Interpretation, Computer-Assisted; Linezolid; Organophosphates; Oxazoles; Oxazolidinones; Skin Diseases, Bacterial; United States | 2014 |
Tedizolid for 6 days versus linezolid for 10 days for acute bacterial skin and skin-structure infections (ESTABLISH-2): a randomised, double-blind, phase 3, non-inferiority trial.
Topics: Acetamides; Administration, Intravenous; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Double-Blind Method; Female; Humans; Linezolid; Male; Middle Aged; Organophosphates; Oxazoles; Oxazolidinones; Skin Diseases, Bacterial; Treatment Outcome; Young Adult | 2014 |
Clinician-reported lesion measurements in skin infection trials: Definitions, reliability, and association with patient-reported pain.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Double-Blind Method; Female; Humans; Male; Middle Aged; Organophosphates; Oxazoles; Pain; Reproducibility of Results; Research Design; Skin Diseases, Bacterial; Wounds and Injuries; Young Adult | 2016 |
Clinical Response of Tedizolid versus Linezolid in Acute Bacterial Skin and Skin Structure Infections by Severity Measure Using a Pooled Analysis from Two Phase 3 Double-Blind Trials.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Double-Blind Method; Humans; Linezolid; Organophosphates; Oxazoles; Skin; Skin Diseases, Bacterial; Staphylococcal Skin Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus pyogenes; Young Adult | 2017 |
Phase 2, randomized, double-blind, dose-ranging study evaluating the safety, tolerability, population pharmacokinetics, and efficacy of oral torezolid phosphate in patients with complicated skin and skin structure infections.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Double-Blind Method; Female; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Organophosphates; Oxazoles; Oxazolidinones; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Skin Infections; Staphylococcus aureus; Treatment Outcome; Young Adult | 2011 |
Other Studies
15 other study(ies) available for oxazoles and Bacterial Skin Diseases
Article | Year |
---|---|
Safety and Tolerability of More than Six Days of Tedizolid Treatment.
Topics: Anti-Bacterial Agents; Humans; Organophosphates; Oxazoles; Oxazolidinones; Retrospective Studies; Skin Diseases, Bacterial; Tetrazoles | 2020 |
Radiolabeled Tedizolid Phosphate Liposomes for Topical Application: Design, Characterization, and Evaluation of Cellular Binding Capacity.
Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Drug Compounding; Drug Delivery Systems; Drug Liberation; Humans; Liposomes; Organophosphates; Oxazoles; Skin Diseases, Bacterial; Technetium | 2021 |
Efficacy and safety of tedizolid in a patient with linezolid-induced neutropenia: A case report.
Topics: Anti-Bacterial Agents; Humans; Linezolid; Microbial Sensitivity Tests; Neutropenia; Organophosphates; Oxazoles; Oxazolidinones; Skin Diseases, Bacterial; Tetrazoles | 2021 |
Antibiotics for skin infections: new study design and a step toward shorter course therapy.
Topics: Anti-Infective Agents; Female; Humans; Male; Organophosphates; Oxazoles; Skin Diseases, Bacterial | 2013 |
End points in trials of treatments for skin infections.
Topics: Anti-Infective Agents; Female; Humans; Male; Organophosphates; Oxazoles; Skin Diseases, Bacterial | 2013 |
End points in trials of treatments for skin infections--reply.
Topics: Anti-Infective Agents; Female; Humans; Male; Organophosphates; Oxazoles; Skin Diseases, Bacterial | 2013 |
New antibiotics for skin and skin-structure infections.
Topics: Acetamides; Anti-Bacterial Agents; Female; Humans; Linezolid; Male; Organophosphates; Oxazoles; Oxazolidinones; Skin Diseases, Bacterial | 2014 |
Tedizolid population pharmacokinetics, exposure response, and target attainment.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Area Under Curve; Biological Availability; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Neutrophils; Organophosphates; Oxazoles; Oxazolidinones; Platelet Count; Prodrugs; Skin Diseases, Bacterial; Staphylococcal Infections; Tetrazoles; Young Adult | 2014 |
A closer inspection of tedizolid.
Topics: Acetamides; Anti-Bacterial Agents; Female; Humans; Male; Organophosphates; Oxazoles; Oxazolidinones; Skin Diseases, Bacterial | 2015 |
A closer inspection of tedizolid.
Topics: Acetamides; Anti-Bacterial Agents; Female; Humans; Male; Organophosphates; Oxazoles; Oxazolidinones; Skin Diseases, Bacterial | 2015 |
A closer inspection of tedizolid - authors' reply.
Topics: Acetamides; Anti-Bacterial Agents; Female; Humans; Male; Organophosphates; Oxazoles; Oxazolidinones; Skin Diseases, Bacterial | 2015 |
New Gram Positive Agents to Treat Acute Bacterial Skin and Skin Structure Infections.
Topics: Anti-Bacterial Agents; Clinical Trials, Phase III as Topic; Costs and Cost Analysis; Glycopeptides; Humans; Lipoglycopeptides; Organophosphates; Oxazoles; Practice Guidelines as Topic; Skin Diseases, Bacterial; Teicoplanin; Treatment Outcome | 2016 |
In vitro activities of tedizolid compared with other antibiotics against Gram-positive pathogens associated with hospital-acquired pneumonia, skin and soft tissue infection and bloodstream infection collected from 26 hospitals in China.
Topics: Anti-Bacterial Agents; China; Cross Infection; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Hospitals; Humans; Microbial Sensitivity Tests; Organophosphates; Oxazoles; Pneumonia, Bacterial; Sepsis; Skin Diseases, Bacterial; Soft Tissue Infections | 2016 |
Early Clinical Response as a Predictor of Late Treatment Success in Patients With Acute Bacterial Skin and Skin Structure Infections: Retrospective Analysis of 2 Randomized Controlled Trials.
Topics: Anti-Bacterial Agents; Clinical Trials, Phase III as Topic; Humans; Linezolid; Models, Statistical; Organophosphates; Oxazoles; Randomized Controlled Trials as Topic; Retrospective Studies; Sensitivity and Specificity; Skin Diseases, Bacterial; Time Factors; Treatment Outcome | 2017 |
Antibiotics.
Topics: Acute Disease; Anti-Bacterial Agents; Glycopeptides; Humans; Lipoglycopeptides; Organophosphates; Oxazoles; Skin Diseases, Bacterial; Teicoplanin | 2017 |